Supraspinal NMDA and non-NMDA receptors are differentially involved in the production of antinociception by morphine and β-endorphin administered itracerebroventriculary in the formalin pain model

Neuropeptides

Volumn 34, Issue 3-4, 2000, Pages 158-166

  Chung, K M ^a   Song, D K ^a   Huh, S O ^a   Kim, Y H ^a   Choi, M R ^a   Suh, H W ^a  

^a Hallym University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; BETA ENDORPHIN; DIZOCILPINE; FORMALDEHYDE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; DOSE RESPONSE; DRUG MECHANISM; HOT PLATE TEST; MALE; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; SPINAL CORD; TAIL FLICK TEST;

EID: 0033766205     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1054/npep.2000.0805     Document Type: Article

References (51)

1. Morphine analgesia in the tail-flick and formalin tests is mediated by different neural systems
2. The formalin test: Scoring properties of the first and second phases of the pain response in rats
3. Antinociceptive profile of intracerebroventricular salmon calcitonin and calcitonin gene-related peptide in the mouse formalin test
4. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat
5. Evidence that adjuvant arthritis in the rat is associated with chronic pain
6. The formalin test: A quantitative study of the analgesic effects of morphine, meperidine and brain stem stimulation in rats and cats
7. The antinociceptive action of supraspinal opioids results from an increase in descending inhibitory control: Correlation of nociceptive behavior abd c-fos expression
8. Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test
9. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse
10. Serotonergic involvement in the antinociceptive action of and the development of tolerance to kappa-opioid receptor agonist, U50, 488H
11. The formalin test in mice: Dissociation between inflammatory and non-inflammatory pain
12. The NMDA receptor: Central role in pain inhibition in rat periaqueductal gray
13. Spinal monoamine and opiate system partly mediate the antinociceptive effects produced by glutamate at brainstem sites
14. Inhibition of spinal nociceptive transmission from the midbrain, pons and medulla in the rat: Activation of descending inhibition by morphine, glutamate and electrical stimulation
15. A new automated method of pain scoring in the formalin test in rats
16. The role of spinal delta 1-opioid receptors in inhibiting the formalin-induced nociceptive response in diabetic mice
17. Noradrenaline regulation of pain-transmission in the spinal cord mediated by alpha-adrenoreceptors
18. Seperate involvement of spinal noradrenergic and serotonergic systems in morphine analgesia: The difference in mechanical and thermal analgesic tests
19. The central nucleus of the amygdala contributes to the production of morphine antinociception in the formalin test
20. Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat
21. Antinociceptive actions of different classes of excitatory amino acid receptor antagonists in mice
22. Interaction between lead acetate and morphine on antinociception in mice by formalin test
23. Differential antinociceptive effects of morphine and methylmorphine in the formalin test
24. Spinal pain suppression mechanisms may differ for phasic and tonic pain
25. Modified formalin: Characteristic biphasic pain response
26. Excitatory amino acid antagonists in the rostral ventromedial medulla inhibit mesencephalic morphine analgesia in rats
27. Differential antagonism by MK-801 against antinociception induced by opioid receptor agonists administered supraspinally in mice
28. β-Endorphin-(1-27) antagonizes β-endorphin but not morphine, D-Pen2-D-Pen5-enkephalin- and U50, 488H-induced analgesia in mice
29. Delta-but not mu-opioid receptors in the spinal cord are involved in antinociception induced by β-endorphin given intracerebroventricularly in mice
30. Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and β-endorphin in mice
31. Intrathecal β-funaltrexamine antagonizes intracerebroventricular β-endorphin- but not morphine-induced analgesia in mice
32. Lack of antinociceptive cross-tolerance between intracerebroventricularly administered β-endorphin and morphine or DPDPE in mice
33. Differential mechanisms mediating β-endorphin-and morphine-induced analgesia in mice
34. Non-NMDA receptor antagonist attenuates antinociception induced by morphine but not beta-endorphin, D-Pen2-D-Pen5-enkephalin and U50, 488H administered intracerebroventricularly in mice
35. Multiplicative interaction between intrathecally and intracerebroventricularly administered morphine for antinociception in the mouse: Involvement of supraspinal NMDA but not non-NMDA receptors
36. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801
37. Spinal delta2 but deltal opioid receptors are involved in intracerebroventricular β-endorphin-induced antinociception in the mouse
38. Involvement of epsilon and kappa opioid receptors in inhibition of the tail-flick response induced by bremazocine in the mouse
39. 5-enkephalin antibody blocks analgesia induced by intracerebroventricular β-endorphin but not morphine in mice
40. Release of immunoreactive Met-enkephalin from the spinal cord by intraventricular β-endorphin but not morphine in anesthetized rats
41. Descending modulation of central neural plasticity in the formalin pain test
42. NMDA receptor antagonist MK-801 blocks non-opioid stress-induced analgesia in the formalin test
43. Standardization of the rat paw formalin test for the evaluation of analgesics
44. The rat paw formalin test: Comparison of noxious agents
45. Central and systemic morphine-induced antinociception in mice: Contribution of descending serotonergic and noradrenergic pathways
46. Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal grey
47. Ethical guidelines for investigations of experimental pain in conscious animals